𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid

✍ Scribed by Salim Hadad; Tom B. Vree; Eppo Van Der Kleijn; Meir Bialer


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
464 KB
Volume
14
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The pharmacokinetics of the following two polyesteric prodrugs of valproic acid (VPA) have been investigated: 1,4‐butanediol divaiproate (BDV) and glyceryl trivalproate (GTV). In addition, the anticonvulsant activity of these compounds has been evaluated and compared to that of VPA and valpromide (VPD). Valproic acid, and its two esteric derivatives were administered intravenously to six dogs at an equivalent dose (400 mg VPA) and their pharmacokinetics investigated. In the case of BDV, the biotransformation to VPA was complete, but in the case of GTV, it was only partial. Of the two investigated esteric prodrugs of VPA, only BDV demonstrated anticonvulsant activity and showed less neurotoxicity than VPA and VPD, and therefore had a better protective index. The anticonvulsant activity is explained on pharmacokinetic and pharmacodynamic grounds due to its complete conversion to VPA and the possible synergism in anticonvulsant activity between VPA and 1,4‐butanediol.


πŸ“œ SIMILAR VOLUMES


Comparative pharmacokinetic analysis of
✍ Meir Bialer; Michael Friedman; Joseph Dubrovsky πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 385 KB πŸ‘ 1 views

A new sustained release dosage form of valproic acid (VPA) was developed. The new sustained release dosage form was administered (twice, with and without food) to five dogs in comparison to a standard tablet (Depakine, Labaz) and an i.v. preparation of the drug. Drug level monitoring in the plasma w

Pharmacokinetic analysis and antiepilept
✍ Salim Hadad; Meir Bialer πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 1 views

Valproyl glycinamide (TV 1901-VPGD) is a new antiepileptic drug, which is currently undergoing clinical trials. The present study explored the pharmacokinetics and pharmacodynamics (anticonvulsant activity and neurotoxicity) of two new isomers of valproyl glycinamide: valnoctyl glycinamide (VCGD) an